Thanks, Biocept for helping students get back to a closer community environment. Your contribution will be meaningful to so many aspiring learners!

To create connection in disconnected times, it helps to get creative. Sharing a virtual experience can be a meaningful way to create understanding and educate your audience - all without the need for hand sanitizer! #LifeSciences #CYTO2021

Deep Pharma Intelligence released The Digest of Global AI in Pharma Investment Check it out deep-pharma.tech/investment-dig… Aizon @allelica1 Altis Labs amplion Antidote ApexQubit Arctoris Ardigen Arrakis Therapeutics Arzeda Athelas @AtomwiseInc

Many thanks to our colleagues Nanocellect for sharing their Amplion success story. So excited to see this stellar team exceeding their goals and getting more wins! #leadgeneration #prospecting #lifesciences hubs.li/H0TZ0h30

Looking to arm your inside sales team for record-setting success? Check out how the team Nanocellect accelerated their wins by empowering their team with Amplion insights. 🎉 #insidesales #prospecting #lifesciences #success hubs.li/H0TZ0jn0

Is your sales team missing your best pharma prospects? It’s almost impossible not to without the right tech. Here we explore solutions to help you stop the madness. hubs.li/Q017f7tb0

We’re excited to announce that we are now part of Science & Medicine Group! amplion.com/press-release/…

Wishing you and yours a wonderful Thanksgiving.

New Year, New Strategy! Keep that resolution to make 2023 your most successful year. Learn how we can help you amp up your #revenue pipeline #leadgen #MachineLearning buff.ly/3l9yHX8

💰 So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage #Biotech and #Biopharma companies - down from 92 or a 27% decrease during the same period last year. 📉 See the whole list here... amplion.com/news/seed-and-…

🧬 More than 50 #Pharma orgs have made significant advances in #GeneTherapies this year - ranging from early research to #ClinicalTrials. amplion.com/news/gene-ther…

💊 We took a look at the #IND meetings and filings with the #FDA in 2023 and found 23 emerging #pharma companies you should track as they progress their therapies to #clinicaltrials. amplion.com/news/investiga…

🔬 #CellTherapy preclinical development continues to be a strong focus in 2023, with leaders such as Novartis and Gilead Sciences - as well as several #EmergingBiopharma orgs. Follow the link to see our list of orgs to track. amplion.com/news/preclinic…

🧬🔬🧑🏽‍🔬 We've seen quite a few #EmergingBiopharmas gaining traction in the lab and with investors this year - despite the macroeconomic conditions. Here's our top 10 list to track AND read the whole post for several bonus orgs to track. amplion.com/news/emerging-…

👩🏽‍🔬 #ESMO23 is coming up fast... so we've compiled some key takeaways from the #Pharma #Oncology landscape to help you prepare! amplion.com/news/top-eu-on…

Searching for European #EmergingBiopharmas that you should be connecting with at #ESMO2023? Here's our list of the 8 most innovative #Cancer pipelines to watch in 2023 amplion.com/news/european-…

🔬 So far in 2023, seven European Pharma #Oncology programs have disclosed #Preclinical #Biomarker targets. Here's the list to help you prep for ESMO - Eur. Oncology conference coming up in Oct. amplion.com/news/advances-…